4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-23-019370
Director bought 30,000 shares at $13.20 ($396,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC Director | 2023-09-19 | Purchase | +30,000 | $13.20 | $396,000 | 1,873,833 | I |
| Open-market purchases · 30,000 sh · avg $13.20 · $396,000 | |||||||
Loading xslF345X05/doc4.xml…